ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Countermeasures to Oncology Trial Failure: 5 Smarter Approaches to Trial Design and Analysis
Countermeasures to Oncology Trial Failures.
CRO Industry Update
Just as drug products have become increasingly complex, regulatory and payer demands have added complexities and costs to drug development.
Postmarket Surveillance and M&A
Vicki Anastasi discusses how a merger or acquisition can impact your medical device’s postmarket surveillance strategy.
What Errors Do We Miss in Clinical Trials
Examining the deficits in current risk mitigation approaches.
5 Things to Know About ICH GCP (R2) 2016
The rising risk of errors, particularly those with complex sources that may be difficult to ascertain in large organizations.
In this article Dr. Martin Lachs explains about ongoing clinical trials in the oncology area.
Free-living Physical Activity in COPD Patients
Deriving methodology standards for clinical trials through a review of research studies.
Major trends in drug development will reshape the global investigative site landscape.
Pharma R&D is Now Biomarker-Driven
Biomarkers are becoming an essential part of the drug discovery and development process.
Go and No Go Decisions – Optimizing Design Strategies
Hear perspectives on utilizing historical data and employing clinically meaningful outcomes in a clinical trial design.